当前位置:首页 - 行情中心 - 华熙生物(688363) - 财务分析 - 现金流量表

华熙生物

(688363)

  

流通市值:260.06亿  总市值:260.06亿
流通股本:4.82亿   总股本:4.82亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金3,353,715,907.952,412,552,080.061,167,445,753.715,608,174,664.93
  收到的税费返还24,986,150.6615,826,940.9210,810,366.7544,017,376
  收到其他与经营活动有关的现金107,753,484.3467,397,801.7228,007,033.85233,135,299.83
  经营活动现金流入小计3,486,455,542.952,495,776,822.71,206,263,154.315,885,327,340.76
  购买商品、接受劳务支付的现金847,703,235.74597,234,503.6338,566,048.691,483,984,780.3
  支付给职工以及为职工支付的现金915,887,663.34660,268,627.26382,972,583.371,266,864,627.64
  支付的各项税费201,999,259161,984,621.6460,877,578.28524,286,123.46
  支付其他与经营活动有关的现金1,212,106,353.74857,956,812.29446,823,985.262,045,686,675.44
  经营活动现金流出小计3,177,696,511.822,277,444,564.791,229,240,195.65,320,822,206.84
  经营活动产生的现金流量净额308,759,031.13218,332,257.91-22,977,041.29564,505,133.92
二、投资活动产生的现金流量:
  收回投资收到的现金128,966.58---
  取得投资收益收到的现金6,804,511.99946,443.22843,818.2232,790,190.37
  处置固定资产、无形资产和其他长期资产收回的现金净额2,250,645.551,738,491-210,493.38
  收到的其他与投资活动有关的现金331,000,00090,000,00030,000,010.4645,000,000
  投资活动现金流入小计340,184,124.1292,684,934.2230,843,828.62678,000,683.75
  购建固定资产、无形资产和其他长期资产支付的现金225,471,073.33151,146,165.7395,764,198.81721,388,155.61
  投资支付的现金42,527,00010,910,0006,010,000287,978,213.3
  支付其他与投资活动有关的现金243,960,00060,000,000-130,000,000
  投资活动现金流出小计511,958,073.33222,056,165.73101,774,198.811,139,366,368.91
  投资活动产生的现金流量净额-171,773,949.21-129,371,231.51-70,930,370.19-461,365,685.16
三、筹资活动产生的现金流量:
  吸收投资收到的现金2,520,0002,520,000--
  其中:子公司吸收少数股东投资收到的现金2,520,0002,520,000--
  取得借款收到的现金217,460,125167,460,125118,460,125149,895,777.78
  筹资活动现金流入小计219,980,125169,980,125118,460,125149,895,777.78
  偿还债务支付的现金202,212,716.84178,126,119.1858,714,344.88114,181,935.16
  分配股利、利润或偿付利息支付的现金54,988,150.481,314,312.41641,663.75185,929,313.08
  支付其他与筹资活动有关的现金50,838,125.1536,452,054.289,557,578.29160,303,168.45
  筹资活动现金流出小计308,038,992.47215,892,485.8768,913,586.92460,414,416.69
  筹资活动产生的现金流量净额-88,058,867.47-45,912,360.8749,546,538.08-310,518,638.91
四、汇率变动对现金及现金等价物的影响11,025,045.2112,791,476.545,343,906.67,811,616.52
五、现金及现金等价物净增加额59,951,259.6655,840,142.07-39,016,966.8-199,567,573.63
  加:期初现金及现金等价物余额613,492,408.37613,492,408.37613,492,408.37813,059,982
  期末现金及现金等价物余额673,443,668.03669,332,550.44574,475,441.57613,492,408.37
补充资料:
  净利润-220,803,434.47-168,405,915.37
  资产减值准备-41,390,475.33-159,086,390.37
  固定资产和投资性房地产折旧-135,862,616.19-214,462,756.17
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-135,862,616.19-214,462,756.17
  无形资产摊销-13,262,602.74-24,763,533.21
  长期待摊费用摊销-17,470,579.81-30,182,521.43
  处置固定资产、无形资产和其他长期资产的损失-445,465.9-118,904.82
  固定资产报废损失-865,841.33-856,263.53
  公允价值变动损失--556,788.66--1,415,364
  财务费用--8,393,065.66-2,456,846.68
  投资损失-5,773,140.64-12,536,457.12
  递延所得税-15,508,744.11--19,104,001.71
  其中:递延所得税资产减少-15,715,976.84--18,580,934.34
    递延所得税负债增加--207,232.73--523,067.37
  存货的减少-38,106,528.73--141,486,852.64
  经营性应收项目的减少--60,123,174.28--86,546,245.42
  经营性应付项目的增加--258,782,439.7-98,059,596.94
  其他-3,366,403.06-11,541,952.2
  不涉及现金收支的投资和筹资活动金额其他项目-30,171,435.5-158,230,980.63
  现金的期末余额-669,332,550.44-613,492,408.37
  减:现金的期初余额-613,492,408.37-813,059,982
  现金及现金等价物的净增加额-55,840,142.07--199,567,573.63
公告日期2025-10-292025-08-272025-04-262025-04-11
审计意见(境内)标准无保留意见
TOP↑